Một khuôn mẫu mới cho sự sinh ra các loài phản ứng được xúc tác bởi XOR trong nội mô

Harrison R. Structure and function of xanthine oxidoreductase: where are we now?. Free Radic Biol Med 2002;33(6):774–97. Kelley EE, Hock T, Khoo NK, Richardson GR, Johnson KK, Powell PC, et al. Moderate hypoxia induces xanthine oxidoreductase activity in arterial endo-thelial cells. Free Radic Biol Med 2006;40(6):952–9. Enroth C, Eger BT, Okamoto K, Nishino T, Nishino T, Pai EF. Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion. Proc Natl Acad Sci USA 2000;97(20):10723–28. Nishino T, Okamoto K. The role of the [2Fe-2s] cluster centers in xanthine oxidoreductase. J Inorg Biochem 2000; 82(1–4):43–9. Iwasaki T, Okamoto K, Nishino T, Mizushima J, Hori H. Sequence motif-specific assignment of two [2Fe-2S] clusters in rat xanthine oxidoreductase studied by site-directed mutagenesis. J Biochem 2000;127(5):771–8. Parks DA, Skinner KA, Tan S, Skinner HB. Xanthine oxidase in biology and medicine. In: Gilbert DL, Colton CA, editors. Reactive oxygen species in biological systems. New York, NY: Kluwer Academic/Plenum; 1999. p. 397–420. Harris CM, Massey V. The oxidative half-reaction of xanthine dehydrogenase with NAD; reaction kinetics and steady-state mechanism. J Biol Chem 1997;272(45):28335–41. Aslan M, Freeman BA. Oxidant-mediated impairment of nitric oxide signaling in sickle cell disease – mechanisms and consequences. Cell Mol Biol 2004;50(1):95–105. Aslan M, Ryan TM, Adler B, Townes TM, Parks DA, Thompson JA, et al. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci USA 2001;98(26):15215–20. Butler R, Morris AD, Belch JJ, Hill A, Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000;35:746–51. Fridovich I. Quantitative aspects of the production of superoxide anion radical by milk xanthine oxidase. J Biol Chem 1970;245(16):4053–7. Kelley EE, Khoo NK, Hundley NJ, Malik UZ, Freeman BA, Tarpey MM. Hydrogen peroxideis the major oxidant product of xanthine oxidase. Free Radic Biol Med 2010;48(4):493–8. Stone JR, Yang S. Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal 2006; 8(3–4):243–70. Veal EA, Day AM, Morgan BA. Hydrogen peroxide sensing and signaling. Mol Cell 2007;26(1):1–14. Zhou L, Stanley WC, Saidel GM, Yu X, Cabrera ME. Regulation of lactate production at the onset of ischaemia is independent of mitochondrial NADH/NAD+: insights from in silico studies. J Physiol 2005; 569(Pt 3):925–37. Harris CM, Massey V. The reaction of reduced xanthine dehydrogenase with molecular oxygen. Reaction kinetics and measurement of superoxide radical. J Biol Chem 1997;272(13):8370–9. Granell S, Gironella M, Bulbena O, Panes J, Mauri M, Sabater L, et al. Heparin mobilizes xanthine oxidase and induces lung inflammation in acute pancreatitis. Crit Care Med 2003;31(2):525–30. Houston M, Estevez A, Chumley P, Aslan M, Marklund S, Parks DA, et al. Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. J Biol Chem 1999;274(8):4985–94. Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 2002;106(24):3073–8. Parks DA, Williams TK, Beckman JS. Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation. Am J Physiol 1988;254(5 Pt 1):G768–74. Fukushima T, Adachi T, Hirano K. The heparin-binding site of human xanthine oxidase. Biol Pharm Bull 1995;18(1):156–8. Adachi T, Fukushima T, Usami Y, Hirano K. Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. Biochem J 1993; 289(Pt 2):523–7. Kelley EE, Trostchansky A, Rubbo H, Freeman BA, Radi R, Tarpey MM. Binding of xanthine oxidase to glycosaminoglycans limits inhibition by oxypurinol. J Biol Chem 2004;279(36):37231–34. Godber BLJ, Doel JJ, Sapkota GP, Blake DR, Stevens CR, Eisenthal R, et al. Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase. J Biol Chem 2000;275(11):7757–63. Millar TM, Stevens CR, Benjamin N, Eisenthal R, Harrison R, Blake DR. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett 1998;427(2):225–8. Li H, Samouilov A, Liu X, Zweier JL. Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction. Evaluation of its role in nitric oxide generation in anoxic tissues. J Biol Chem 2001;276(27): 24482–89. Maia LB, Moura JJ. Nitrite reduction by xanthine oxidase family enzymes: a new class of nitrite reductases. J Biol Inorg Chem 2011;16(3):443–60. Li H, Cui H, Kundu TK, Alzawahra W, Zweier JL. Nitric oxide production from nitrite occurs primarily in tissues not in the blood: critical role of xanthine oxidase and aldehyde oxidase. J Biol Chem 2008;283(26):17855–63. Alef MJ, Vallabhaneni R, Carchman E, Morris Jr SM, Shiva S, Wang Y, et al. Nitrite-generated NO circumvents dysregulated arginine/NOS signaling to protect against intimal hyperplasia in Sprague–Dawley rats. J Clin Invest 2011;121(4):1646–56. Samal AA, Honavar J, Brandon A, Bradley KM, Doran S, Liu Y, et al. Administration of nitrite after chlorine gas exposure prevents lung injury: effect of administration modality. Free Radic Biol Med 2012;53(7):1431–9. Pickerodt PA, Emery MJ, Zarndt R, Martin W, Francis RC, Boemke W, et al. Sodium nitrite mitigates ventilator-induced lung injury in rats. Anesthesiology 2012;117(3):592–601. Sugimoto R, Okamoto T, Nakao A, Zhan J, Wang Y, Kohmoto J, et al. Nitrite reduces acute lung injury and improves survival in a rat lung transplantation model. Am J Transplant 2012;12(11):2938–48. Zuckerbraun BS, Shiva S, Ifedigbo E, Mathier MA, Mollen KP, Rao J, et al. Nitrite potently inhibits hypoxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidoreductase-dependent nitric oxide generation. Circulation 2010;121(1):98–109. Baker JE, Su J, Fu X, Hsu A, Gross GJ, Tweddell JS, et al. Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and K(ATP) channels. J Mol Cell Cardiol 2007;43(4):437–44. Tripatara P, Patel NS, Webb A, Rathod K, Lecomte FM, Mazzon E, et al. Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase. J Am Soc Nephrol 2007;18(2):570–80. Webb A, Bond R, McLean P, Uppal R, Benjamin N, Ahluwalia A. Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia–reperfusion damage. Proc Natl Acad Sci USA 2004;101(37):13683–88. Lu P, Liu F, Yao Z, Wang CY, Chen DD, Tian Y, et al. Nitrite-derived nitric oxide by xanthine oxidoreductase protects the liver against ischemia–reperfusion injury. Hepatobiliary Pancreat Dis Int 2005;4(3):350–5. Huang L, Borniquel S, Lundberg JO. Enhanced xanthine oxidoreductase expression and tissue nitrate reduction in germ free mice. Nitric Oxide 2010;22(2):191–5. Vitturi DA, Patel RP. Current perspectives and challenges in understanding the role of nitrite as an integral player in nitric oxide biology and therapy. Free Radic Biol Med 2011;51(4):805–12. Bueno M, Wang J, Mora AL, Gladwin MT. Nitrite signaling in pulmonary hypertension: mechanisms of bioactivation, signaling, and therapeutics. Anti-oxid Redox Signal 2012;18(14):1797–809. Weitzberg E, Hezel M, Lundberg JO. Nitrate-nitrite-nitric oxide pathway: implications for anesthesiology and intensive care. Anesthesiology 2010;113(6):1460–75. Takano Y, Hase-Aoki K, Horiuchi H, Zhao L, Kasahara Y, Kondo S, et al. Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase. Life Sci 2005;76(16):1835–47. Becker MA, Schumacher Jr HR, Wortmann RL, MacDonald PA, Eustace D, Palo WA, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005;353(23):2450–61. Hille R, Nishino T, Bittner F. Molybdenum enzymes in higher organisms. Coord Chem Rev 2011; 255(9–10):1179–205. Havemeyer A, Bittner F, Wollers S, Mendel R, Kunze T, Clement B. Identification of the missing component in the mitochondrial benzamidoxime prodrug-converting system as a novel molybdenum enzyme. J Biol Chem 2006;281(46):34796–802. Wang J, Fischer K, Zhao X, Tejero J, Kelley EE, Wang L, et al. Novel function of sulfite oxidase as a nitrite reductase that generates nitric oxide. Free Radic Biol Med 2010;49:S122. Wang J, Krizowski S, Fischer-Schrader K, Niks D, Tejero J, Sparacino-Watkins C, et al. Sulfite oxidase catalyzes single-electron transfer at molybdenum domain to reduce nitrite to nitric oxide. Antioxid Redox Signal 2014. PMID: 25314640. Li H, Kundu TK, Zweier JL. Characterization of the magnitude and mechanism of aldehyde oxidase-mediated nitric oxide production from nitrite. J Biol Chem 2009;284(49):33850–58. Sparacino-Watkins CE, Tejero J, Sun B, Gauthier MC, Thomas J, Ragireddy V, et al. Nitrite reductase and nitric-oxide synthase activity of the mitochondrial molybdopterin enzymes mARC1 and mARC2. J Biol Chem 2014;289(15): 10345–58. Kleinbongard P, Dejam A, Lauer T, Rassaf T, Schindler A, Picker O, et al. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med 2003;35(7):790–6. Doel JJ, Godber BLJ, Eisenthal R, Harrison R. Reduction of organic nitrates catalysed by xanthine oxidoreductase under anaerobic conditions. Biochim Biophys Acta 2001; 1527(1–2):81–7. Li H, Cui H, Liu X, Zweier JL. Xanthine oxidase catalyzes anaerobic transformation of organic nitrates to nitric oxide and nitrosothiols: characterization of the mechanism and the link between organic nitrate and guanylyl cyclase activation. J Biol Chem 2005;280(17):16594–600. Lartigue-Mattei C, Chabard JL, Bargnoux H, Petit J, Berger JA, Ristori JM, et al. Plasma and blood assay of xanthine and hypoxanthine by gas chromatography–mass spectrometry: physiological variations in humans. J Chromatogr 1990;529(1):93–101. Pesonen EJ, Linder N, Raivio KO, Sarnesto A, Lapatto R, Hockerstedt K, et al. Circulating xanthine oxidase and neutrophil activation during human liver transplantation. Gastroenterology 1998;114(5):1009–15. Quinlan GJ, Lamb NJ, Tilley R, Evans TW, Gutteridge JM. Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity, and mortality. Am J Respir Crit Care Med 1997;155(2):479–84. Himmel HM, Sadony V, Ravens U. Quantitation of hypoxanthine in plasma from patients with ischemic heart disease: adaption of a high-performance liquid chromatographic method. J Chromatogr 1991;568(1):105–15. Li H, Samouilov A, Liu X, Zweier JL. Characterization of the effects of oxygen on xanthine oxidase-mediated nitric oxide formation. J Biol Chem 2004;279(17):16939–46. Cantu-Medellin N, Kelley EE. Xanthine oxidoreductase-catalyzed reduction of nitrite to nitric oxide: insights regarding where, when and how. Nitric Oxide 2013;34:19–26. Amaya Y, Yamazaki K, Sato M, Noda K, Nishino T. Proteolytic conversion of xanthine dehydrogenase from the NAD-dependent type to the O2-dependent type. Amino acid sequence of rat liver xanthine dehydrogenase and identification of the cleavage sites of the enzyme protein during irreversible conversion by trypsin. J Biol Chem 1990;265(24):14170–75. Stuehr DJ, Santolini J, Wang ZQ, Wei CC, Adak S. Update on mechanism and catalytic regulation in the NO synthases. J Biol Chem 2004;279(35):36167–70.